ACHE and early-onset autosomal dominant Alzheimer disease: Acetylcholinesterase (AChE) is a well-known enzyme for the hydrolysis of the neurotransmitter acetylcholine (ACh)1–4, being the target of the main marketed pharmacological treatment of Alzheimer’s disease (AD).